Status:

COMPLETED

Effects of Prebiotics on Intestinal Colonization and Mood in a University Cohort

Lead Sponsor:

Beneo-Institute

Collaborating Sponsors:

University of Reading

Conditions:

Mood

Eligibility:

All Genders

18-45 years

Phase:

NA

Brief Summary

There is a growing interest within the scientific community of whether prebiotics can aid in clinical outcomes including mood via modulation of the gut microbiota and its resulting metabolites via the...

Detailed Description

Several reports have suggested that poor mental health among university students is on the increase. Factors driving this; including academic pressure, overdemanding workloads, financial concerns, and...

Eligibility Criteria

Inclusion

  • Volunteer is healthy at the time of pre-examination
  • Possess mild/moderately elevated levels of stress
  • Volunteer is aged ≥ 18 to ≤ 45 years at the time of pre-examination
  • Volunteer's BMI is ≥ 18.5 and ≤ 29.9
  • Volunteer has a stool frequency of at least 3 bowel movements per week
  • Volunteer is able and willing to comply with the study instructions
  • Volunteer is suitable for participation in the study according to the investigator/study personnel
  • Written informed consent is given by volunteer

Exclusion

  • No command of any local language
  • Previously or currently diagnosed neurological or psychiatric disorders
  • Previous history of renal, hepatic, cardiovascular disease or clinically significant diabetes
  • Gastrointestinal disorders including IBS, IBD or other conditions that might affect the gut environment
  • Food allergies or intolerances
  • Using drugs (e.g. antibiotics, aspirin, proton pump inhibitors) influencing gastrointestinal function (8 weeks before intervention)
  • Use of laxatives and labelled pre-and probiotics in the previous 4 weeks before the beginning of intervention
  • Volunteers currently involved or will be involved in another clinical or food study
  • History of drug (recreational) or alcohol abuse.
  • Use of anti-depressants medication including selective serotonin receptor inhibitors or Amitriptyline for 3 months prior to commencing the trial
  • Received bowel preparation for investigative procedures in the 4 weeks prior to the study
  • Undergone surgical resection of any part of the bowel.
  • pregnant or lactating

Key Trial Info

Start Date :

January 12 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 19 2022

Estimated Enrollment :

96 Patients enrolled

Trial Details

Trial ID

NCT05212545

Start Date

January 12 2022

End Date

September 19 2022

Last Update

December 20 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Reading

Reading, United Kingdom, RG6 6DZ